News Ticker

Company seeks FDA approval for “female Viagra”

flibanserin

An FDA advisory committee hearing on Thursday looms large for the makers of flibanserin, a drug developed by Sprout Pharmaceutical that is supposed to be the “Viagra for women”.

According to USA Today, if the drug wins over the support of the committee, flibanserin would almost certainly receive the green light from the FDA to begin marketing. This is of course good news for the company (and females) but it would also make it the first FDA approved treatment for female sexual dysfunction. Currently, woman do not have a medical treatment for this condition, but this drug could open a whole slew of new treatment options.

Flibanserin is Sprout’s answer to the most common form of female sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD). This disorder is a persistent biological lack of desire for sex, which also causes distress and typically effects 1 in 10 women. To sort this problem, the drug corrects bio-chemical imbalances in the brain, which then restores sexual desire in premenopausal women. While it has proved effective in pivotal trials, it has yet to be approved as the FDA has not deemed that the side effects (sleepiness, dizziness and nausea) are worth the benefits.

On the market there are currently more than 20 sexual dysfunction treatments for men (eight for erectile dysfunction alone), but the FDA has yet to support a single medical treatment for any form of female sexual dysfunction. While some have accused the FDA of placing significantly less importance on female sexual health than male sexual health, the organization has stated that it recognizes the seriousness of female sexual dysfunction. If the pill hits the market, it would be a good step forward to helping with this problem. Sexual dysfunction in women is a much more complicated interpersonal, physical and psychological issue than in men, and simply taking a pill would not solve every problem. However, it most certainly could help. Whether or not people actually want to use it should it be approved, is up to them.

Joseph Scalise

Joseph Scalise

Staff Writer
Joseph Scalise is an experienced writer who has worked for many different online websites across many different mediums. While his background is mainly rooted in sports writing, he has also written and edited guides, ebooks, short stories and screenplays. In addition, he performs and writes poetry, and has won numerous contests. Joseph is a dedicated writer, sports lover and avid reader who covers all different topics, ranging from space exploration to his personal favorite science, microbiology.
About Joseph Scalise (1726 Articles)
Joseph Scalise is an experienced writer who has worked for many different online websites across many different mediums. While his background is mainly rooted in sports writing, he has also written and edited guides, ebooks, short stories and screenplays. In addition, he performs and writes poetry, and has won numerous contests. Joseph is a dedicated writer, sports lover and avid reader who covers all different topics, ranging from space exploration to his personal favorite science, microbiology.